Invention Grant
US08586550B2 Thiazole derivatives as SGLT2 inhibitors and pharmaceutical composition comprising same
有权
作为SGLT2抑制剂的噻唑衍生物和包含其的药物组合物
- Patent Title: Thiazole derivatives as SGLT2 inhibitors and pharmaceutical composition comprising same
- Patent Title (中): 作为SGLT2抑制剂的噻唑衍生物和包含其的药物组合物
-
Application No.: US13704081Application Date: 2011-06-10
-
Publication No.: US08586550B2Publication Date: 2013-11-19
- Inventor: Jinhwa Lee , Jeongmin Kim , Suk Ho Lee , Junwon Lee , Kwang-Seop Song , Eun-Jung Park , Min Ju Kim , Hee Jeong Seo , Sung-Han Lee , Eun Jung Son , Jong Yup Kim , Suk Youn Kang , Younggyu Kong
- Applicant: Jinhwa Lee , Jeongmin Kim , Suk Ho Lee , Junwon Lee , Kwang-Seop Song , Eun-Jung Park , Min Ju Kim , Hee Jeong Seo , Sung-Han Lee , Eun Jung Son , Jong Yup Kim , Suk Youn Kang , Younggyu Kong
- Applicant Address: KR Yongin-Si, Gyeonggi-Do
- Assignee: Green Cross Corporation
- Current Assignee: Green Cross Corporation
- Current Assignee Address: KR Yongin-Si, Gyeonggi-Do
- Agency: Alston & Bird LLP
- International Application: PCT/KR2011/004273 WO 20110610
- International Announcement: WO2011/159067 WO 20111222
- Main IPC: A61K31/70
- IPC: A61K31/70 ; A61K31/425 ; C07H5/04 ; C07H5/06 ; C07D277/60
Abstract:
The present invention relates to a novel compound with thiazole ring having an inhibitory activity against sodium-dependent glucose cotransporter 2 (SGLT2) being present in the intestine and kidney, and a pharmaceutical composition comprising the same as an active ingredient, which is useful for preventing or treating metabolic disorders, particularly diabetes.
Public/Granted literature
- US20130090298A1 Thiazole Derivatives as SGLT2 Inhibitors and Pharmaceutical Composition Comprising Same Public/Granted day:2013-04-11
Information query
